Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 04/02/20221 min di lettura
Assessment of Pressor Effects of Drugs; Revised Draft Guidance for Industry; Availability
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for industry entitled "Assessment of Pressor Effects of Drugs." This draft guidance is intended to advise sponsors on the premarketing assessment of a drug's effect on blood pressure. Elevated blood pressure is known to increase the risk of stroke, heart attack, and death. The effect of a drug on blood pressure is, therefore, an important consideration in risk assessment and product labeling. This draft guidance revises the draft guidance for industry "Assessment of Pressor Effects of Drugs" issued on May 31, 2018.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →